Skip to content
★ Sign in to follow
TH

Thomas H. Robinson

Executive
Harvard Apparatus Regenerative Technology, Inc.Cynosure Inc
Total declarations
39
Companies
2
▲ Purchases (5 ops.)
€287k
▼ Sales (9 ops.)
€1.2M

Latest filing published 28 Mar 2018 for Harvard Apparatus Regenerative Technology, Inc..

Insider track record

Disclosed buys
5
Disclosed sells
9
Signal history

Closed purchases

Market purchases
5
Positive at T+90
0%
Median T+90
-22.5%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Thomas H. Robinson: trading record in brief

Thomas H. Robinson is a declared insider at 2 companies; the most frequent names are Cynosure Inc and Harvard Apparatus Regenerative Technology, Inc. Between 5 March 2007 and 14 March 2018, the trades on record add up to 39 filings.

On the open market, the record shows 5 purchases worth €287k and 9 sales worth €1.2M. Sales outweigh purchases by €872k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 4 share grants and 20 option exercises.

The median purchase comes to €33k.

The record was last updated on 28 March 2018 with an option exercise in Harvard Apparatus Regenerative Technology, Inc. The clock since the last published purchase (14 June 2016) now reads 3,799 days. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Thomas H. Robinson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations35 total

25 of 35 declarations